Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05208489
Other study ID # 14677
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date December 16, 2021
Est. completion date June 2023

Study information

Verified date January 2022
Source New York Medical College
Contact Anuritha Tirumani, MBBS
Phone 914-493-3470
Email anuritha.tirumani@wmchealth.org
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

It is a retrospective study. Patients, who presented with either traumatic or general surgery emergencies, undergone exploratory laparotomy, had an open abdomen management and received Direct Peritoneal Resuscitation in addition to standard resuscitation will be considered as meeting the criteria to collect the data.


Description:

Due to the high volume of patient transfers from different facilities with difficult intra-abdominal pathologies and the high case-mix index at Westchester Medical Center, we see many patients who require re-operations and open abdominal management. Since July1st of 2020 we have been using DPR in addition to standard iv fluids on all patients who undergo open abdominal management and it is now standard of care at our facility. we plan to collect the data from all qualified subjects who received DRP since 7/1/2020 to 6/30/2022.


Recruitment information / eligibility

Status Recruiting
Enrollment 108
Est. completion date June 2023
Est. primary completion date June 30, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adult patients 18 years of age or older. - Trauma or General surgery patients who undergo emergency abdominal surgery via laparotomy and who had open abdominal management during the index procedure at our institution. - Patients who are transferred to our institution with an already open abdomen will also be eligible if they required continued open abdominal management. Exclusion Criteria: - Patients <18 years are excluded.

Study Design


Intervention

Other:
there is no intervention involved in this study
there is no intervention involved in this study.

Locations

Country Name City State
United States New York Medical College Valhalla New York

Sponsors (1)

Lead Sponsor Collaborator
New York Medical College

Country where clinical trial is conducted

United States, 

References & Publications (3)

Crafts TD, Hunsberger EB, Jensen AR, Rescorla FJ, Yoder MC, Markel TA. Direct peritoneal resuscitation improves survival and decreases inflammation after intestinal ischemia and reperfusion injury. J Surg Res. 2015 Dec;199(2):428-34. doi: 10.1016/j.jss.20 — View Citation

Smith JW, Garrison RN, Matheson PJ, Franklin GA, Harbrecht BG, Richardson JD. Direct peritoneal resuscitation accelerates primary abdominal wall closure after damage control surgery. J Am Coll Surg. 2010 May;210(5):658-64, 664-7. doi: 10.1016/j.jamcollsurg.2010.01.014. — View Citation

Zakaria el R, Hurt RT, Matheson PJ, Garrison RN. A novel method of peritoneal resuscitation improves organ perfusion after hemorrhagic shock. Am J Surg. 2003 Nov;186(5):443-8. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Post operative outcomes intra abdominal infections and other complications through out the hospitalization and 30 days after discharge.
Secondary length of hospital stay includes ICU stay, ventilator days and mortality. post procedure to 30 days after discharge.
See also
  Status Clinical Trial Phase
Completed NCT00332696 - Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis Phase 2
Completed NCT00216372 - Efficacy and Safety of Lanreotide Microparticles as Palliative Treatment in Peritoneal Carcinomatosis Phase 3
Withdrawn NCT02928458 - Clinical and Financial Impact of an Evidenced-Based Adhesive Small Bowel Obstruction Management Protocol N/A
Completed NCT00758186 - Randomized Trial of Colonic Stents as a Bridge to Surgery Phase 3
Completed NCT02275338 - Study to Assess Efficacy and Safety of Lanreotide Autogel 120 MG in Treatment of Clinical Symptoms Associated With Inoperable Malignant Intestinal Obstruction Phase 2
Completed NCT03997721 - Pathophysiology of Perioperative Fluid Management in Emergency Laparotomy
Recruiting NCT01669044 - Comparison the Hemodynamics Effects Between Dexmedetomidine and Propofol in Major Abdominal Surgical Patients N/A
Completed NCT01596764 - Effects of Methylnaltrexone in Comparison to Naloxone on Loperamide-induced Delay of the Oro-cecal, Whole-gut and Colon Transit Time. Phase 1
Completed NCT04020939 - The Role of Indocyanine Green Angiography Fluorescence on Intestinal Resections in Pediatric Surgery. N/A
Active, not recruiting NCT05229822 - Bacterial Translocation Markers as Predictors of Infectious and Inflammatory Complications in Acute Bowel Obstruction
Recruiting NCT06072976 - The Influence of Feeding Source on the Gut Microbiome and Time to Full Feeds in Neonates With Congenital Gastrointestinal Pathologies N/A
Completed NCT01899885 - Acute High-risk Abdominal Surgery Study - an Optimized Perioperative Course N/A
Completed NCT00130715 - Seprafilm in the Reduction of Incidence of Bowel Obstruction in General Surgery N/A
Not yet recruiting NCT01125280 - Prospective Multicenter Validation of a Severity Score of Strangulated Small Bowel Occlusion N/A
Recruiting NCT06245577 - Biological Mesh Versus Synthetic Mesh in Interdisciplinary RRP With SCP N/A
Terminated NCT02365584 - Quality of Life in Patients With Inoperable Malignant Bowel Obstruction Phase 2
Completed NCT01596777 - Effects of 500 mg Immediate Release and Extended Release Methylnaltrexone on Loperamide-induced Delay of the Oro-cecal and Whole-gut Transit Time in Healthy Subjects Phase 1
Not yet recruiting NCT04213976 - Ostomy in Continuity or Conventional Ileostomy: a Retrospective Multicentric Analysis
Completed NCT03663023 - Band Adhesions in Relation to Previous Abdominal Surgery
Active, not recruiting NCT03773237 - Intralipid Versus SMOFlipid in HPN Patients N/A